Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind exten
about
PCSK9 inhibition in statin-intolerant HeFH patients: What's new?Minimizing nocebo effect: Pragmatic approach.Nocebo effects can make you feel pain.Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect.Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care.Serious Adverse Events Among SPRINT Trial Participants Taking Statins at Baseline.The effectiveness and cost-effectiveness of plant sterol or stanol-enriched functional foods as a primary prevention strategy for people with cardiovascular disease risk in England: a modeling study.Suboptimal use of statins for secondary cardiovascular prevention: a "planetary" issue.Haben wir Ärzte Angst vor Statinen?Now is good, earlier is better.[Statin-associated muscle symptoms].The year in cardiology 2017: prevention.[Placebo and nocebo : How can they be used or avoided?]Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case-control study.Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.Nonadherence to statins: individualized intervention strategies outside the pill box.Temporal Trends of High-Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention.Prevention and management of statin adverse effects: A practical approach for pharmacists.Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
P2860
Q40114602-3B005340-BD80-4263-91EA-4F4A07968F98Q44863430-04037F4B-61A8-46F2-ADA2-A1EF3214D9C8Q47103163-CB9C2283-7D6D-4862-8741-A29091A5056AQ47106974-5442F22A-7A6C-467E-A59C-14495B64435AQ47123968-BFC05BEA-6EFB-4361-9288-865BE9B4CA1FQ47336691-7DDD310E-90F0-4DBF-84EF-308681006056Q47624902-544E1D4C-453B-4EAB-8691-9258D973BC12Q48341546-BF8DE6FF-4590-4513-B67D-6B98E8729E55Q49796601-D932EBFC-586C-4B23-A882-4B3780AF9372Q49820916-04B655F1-5ED9-4B05-B0E3-0A1A439965AFQ50041485-35403854-2A2A-4B4C-86B0-98B089D9B1D7Q50193445-B2EA5590-0853-4E5D-AEA8-4E2296023FECQ52682921-29DDF229-962D-4E3C-9ABD-EE8B48576CFCQ52688656-C82697B9-A267-4189-84B0-F4D749F74392Q53099880-C0C3DD76-520F-420B-9365-7A7F5D2AB758Q53833642-5602FDA5-F41E-47CE-9D68-9E92669AD433Q55011566-21450B29-139A-4886-91CC-35984037DE4CQ55102883-C1EFB854-A655-4360-A269-20AAD55041F9Q55154739-8F29CD14-DA12-4110-A71D-3F35A31D4174Q56984696-B90DF7CB-DE21-46C7-947A-B66E69426B2F
P2860
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind exten
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Adverse events associated with ...... non-randomised non-blind exten
@en
Adverse events associated with ...... non-randomised non-blind exten
@nl
type
label
Adverse events associated with ...... non-randomised non-blind exten
@en
Adverse events associated with ...... non-randomised non-blind exten
@nl
prefLabel
Adverse events associated with ...... non-randomised non-blind exten
@en
Adverse events associated with ...... non-randomised non-blind exten
@nl
P2093
P1433
P1476
Adverse events associated with ...... non-randomised non-blind exten
@en
P2093
ASCOT Investigators
Ajay Gupta
Bjorn Dahlof
Neil Poulter
Peter Sever
Rory Collins
Tim Collier
P304
P356
10.1016/S0140-6736(17)31075-9
P407
P577
2017-05-02T00:00:00Z